Work

Multicenter retrospective analysis for efficacy and safety of liposomal irinotecan (nal-IRI) plus 5-FU/leucovorin (5-FU/LV) after progression on gemcitabine-based therapy in Korean patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): A study by Korean Cancer Study Group (KCSG).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.4_suppl.344

Authors: Changhoon Yoo, Hyeon-Su Im, Kyu-Pyo Kim, Do-Youn Oh, Kyung-Hun Lee, Hong Jae Chon, Joo Hoon Kim, Myoung Joo Kang, Il-Hwan Kim, Guk Jin Lee, Sung Yong Oh, Younak Choi, Hye Jin Choi, Seung Tae Kim, Joon Oh Park, Baek-Yeol Ryoo

Institutions: Asan Medical Center, University of Ulsan, Seoul National University Hospital, CHA University Bundang Medical Center, CHA University, Inje University Haeundae Paik Hospital, Catholic University of Korea, Dong-A University, Dongguk University Gyeongju Hospital, Yonsei Cancer Hospital, Samsung Medical Center, Sungkyunkwan University

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2912891270

Cites:

Cited by: 1

Related to: 10